Home |  Elder Rights |  Health |  Pension Watch |  Rural Aging |  Armed Conflict |  Aging Watch at the UN  

  SEARCH SUBSCRIBE  
 

Mission  |  Contact Us  |  Internships  |    

 



back

Fighting Back When 
Foe Is Prostate Cancer

 

By: John Langone
New York Times, October 23, 2001


Never underestimate prostate cancer," Dr. Patrick Walsh, a professor of urology at Johns Hopkins, warns in his book. "It is a formidable adversary, which springs up in several places at once inside the prostate."

Indeed, with an average of seven separate tumors growing inside of it, a cancerous prostate is a challenge that must be met if the patient is not to be one of the estimated 31,500 Americans who die of it each year.

The most effective treatment, if the cancer is confined to the prostate, is still radical prostatectomy, the total removal of the walnut-sized gland which provides a third of the fluid that makes up semen.

But as good as it is, this surgical approach is, as the authors of the two books agree, intended for relatively younger, otherwise healthy men who are not only curable but who can reasonably expect to live at least another 15 or so years.

Dr. Rous, who is a professor of urology at Dartmouth Medical School, and Dr. Walsh also agree that when the operation is performed by well-trained surgeons fewer complications arise, and potency — loss of which may be temporary or permanent after surgery — can be preserved in many men.

The two books cover the same ground, and generally take the same views of various treatments — for example, Dr. Walsh's refers to radiation treatment as "an excellent option" and Dr. Rous's calls it a "very valid and fine means of treating prostate cancer." But Dr. Walsh's book is easier to use because of its organization, comprehensiveness and writing style.

This is not to say that Dr. Rous's work should be ignored. It costs less, is more compact in size and contains all the essential information from anatomy of the prostate to diagnosis, treatments and complications.

But it often bogs down in medical journal terminology like "a urodynamic study is often of benefit in revealing a detrusor/ sphincter dyssnergia."

Dr. Walsh's guide, with easy-to-follow charts, illustrations and sidebars on a variety of topics (treatment pros and cons, cancer staging, diagnostic procedures, diet and exercise, to name a few) makes a complex disease less confusing to the average reader, especially the patient who needs to evaluate his options from watchful waiting to radical surgery.

There are especially valuable sections on the role of environment, diet and race in prostate cancer. For example, Dr. Walsh points out that the disease is common in Western countries and rare in Asia, but when Asian men migrate to the West, their risk, probably because of diet, increases over time. "The risk changes from place to place," he writes, "and in many ways from man to man."

Dr. Walsh also examines the reasons that the number of black men per 100,000 who develop prostate cancer is 40 percent higher than the number of white men and that black men seem to get more severe forms of the disease. Genetic susceptibility, inadequate exposure to vitamin D because black skin is more efficient at blocking out sunlight and diet are possible reasons. The discussion is vital because, as Dr. Walsh writes, black men generally delay seeking medical care.

"African-American men," he advises, "should start screening for prostate cancer at age 40." But he adds that information from certain health care centers, like military clinics or H.M.O.'s where availability of medical care seems to be equal, suggests that black men "still seem to fare poorly when it comes to prostate cancer."

Nonetheless, early detection and improvements in treatment save lives. As Dr. Rous advises, "If prostatic cancer is to be diagnosed at a time when it is still potentially curable, I believe that a blood P.S.A. test (a measure of an enzyme made by the prostate, an elevated level of which can signal cancer) and a digital rectal examination should be done annually in all men over 50 and in men over 40 who are African-American or who have a first-degree relative (a father or brother) in whom prostate cancer was diagnosed before the age of 60."

"Dr. Patrick Walsh's Guide to Surviving Prostate Cancer," by Patrick C. Walsh and Janet Farrar Worthington, Warner Books, $25.95.

"The Prostate Book: Sound Advice on Symptoms and Treatment," by Dr. Stephen N. Rous, W. W. Norton & Company, $26.95.